GERM

ETFMG Treatments Testing and Advancements ETF

GERM tracks a tier-weighted, narrow index of US-listed global biotech companies that are engaged in the testing and treatments of infectious diseases.


Global

EQUITY

Rules-Based

MANAGEMENT STYLE

9.6 M

ASSETS UNDER MGMT

68 bp

EXPENSES
Fund Basics
Fund sponsorETFMG
CategoryGlobal
Asset classEquity
Websitelink...
Inception dateJun 17, 2020
Assets (mns)$10
Expense ratio68 bp
CurrencyUSD
Sector Breakdown
Fund Structure
RegulationOpen-Ended Fund
DistributionsQuarterly
Taxation1099
Stock selectionCommittee
WeightingTiered
Holdings TransparencyFull
Derivatives-basedNo
Options availableYes
Currency hedgedNo
Fund of fundsNo
Top 10 Holdings Complete list  + 
ALNYLAM PHARMACEUTICALS INC 11.1 %
LABCORP HOLDINGS 7.1 %
QUEST DIAGNOSTICS 6.5 %
BIONTECH SE SPONSORED ADR 5.3 %
VAXCYTE, INC. 4.4 %
BIO-RAD LABORATORIES-CL A 4.4 %
QUIDEL CORP 4.3 %
ZAI LAB LTD. UNSPONSORED ADR 3.8 %
BIOCRYST PHARMACEUTICALS INC 3.8 %
DYNAVAX TECHNOLOGIES CORP 3.4 %
Constituent Breakdown
Number of holdings57
Herfindahl-Hirschman Index 422
Wgt avg mkt cap (mns)$38,634
Large cap (>$10bn)44.8%
Mid cap ($2-10bn)9.0%
Small cap (<$2bn)46.3%
Developed mkts.95.8%
Emerging mkts.4.2%
Country Exposure
UNITED STATES 79.7 %
GERMANY 7.2 %
BRITAIN 5.2 %
CHINA 3.8 %
CANADA 1.7 %
FRANCE 1.0 %
JAPAN 0.9 %
Historical Performance


Standardized Performance (as of 08/31/2024)
 YTD1 YR2 YR3 YR5 YR10 YRIncep.
Total Returns -2.5% -0.7% -9.0% -23.8% -- -- -8.5%
Volatility 22.7% 22.0% 27.1% 30.1% -- -- --
Market Correlations
versus...BetaR-squared
S&P 5000.9543%
MSCI EAFE0.9641%
MSCI Emg Mkts0.7424%
Liquidity Measures
Avg. volume (000)3
Turnover0.6%
Avg. Bid/Ask (% of price)0.73%
ADV of underlying (mns)$8,036
Technical Indicators
Recent close$19.16
30d moving avg.$19.14
Annualized volatility26.3%
Relative strength (RSI)54
Short interest (ETF)0.0%
Short interest (underlying)0.0%
Distributions
Assets Under Management (mns)

Money Flows (mns)

Short Interest (as % of shares outstanding)

Long Money Flows (mns)

Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial

Comparable ETFs Based on Overlap
Ticker Fund Name Overlap
vs. GERM
Expenses
vs. GERM
ALTAR Score™
vs. GERM
Risk and Returns: GERM vs. Comps (1 YR)

Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Results & Estimates
  2019 2020 2021 2022 2023 2024E 2025E  
Sales per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Earnings per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Dividends per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Book value per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Valuation Metrics
  2023 2024E Fwd Est 2025E
Price-to-sales --x --x --x --x
Price-to-earnings --x --x --x --x
Price-to-cash flow --x --x --x --x
Price-to-growth --x --x --x --x
Price-to-book value --x --x --x --x
Yield --% --% --x --%
0.0 0.0 0.0 0.0% --
Based on closing prices from 9/12/2024
Historical Valuation Trends Sample data. Subscribe for access.

SHOWING:
Price-to-Earnings
GERM



Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.

Some content on this tab for Individual & Professional subscribers only. Start your FREE trial

ETF Research Center Rating


ALTAR Score™

GERM

0.0%

Cat. Avg

4.0%


ALTAR Score™ Calculation

Category Overview
There are 377 funds in the Global Equity category, with an average ALTAR Score™ of 4.0% and a standard deviation of 4.6%. GERM's ALTAR Score™ is approximately 0.0 standard deviations below the category average. This places GERM in the percentile among funds in the category.
Sell Side Consensus Rating

Sell-side recommendations on the ETF's individual constituents

GERM
Peer Average
SELL
U/W
HOLD
O/W
BUY
Factor Scorecard

SIZE
VALUE
YIELD
MOMENTUM
VOLATILITY
QUALITY
Expense Analysis

Peer Group Rules-Based
Global Equity ETFs
# of ETFs 191
Avg. Expense Ratio 55.4 bp
Std. Deviation 17.5 bp
GERM (68 bp) Percentile rank 76
Peer Group Expense Ratio Distribution


Total Cost of Ownership (TCO) Comparison
Expense (bp)
(A)
Avg. Bid/Ask (bp)
(B)
TCO (bp)
(A)+(B)
GERM 68.0 73.0 141
Peer Avg. 57.1 40.0 97.1
  For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .